2,159 research outputs found

    Using Bernoulli Equation to Solve Burger's Equation

    Get PDF
    In this paper we find the exact solution of Burger's equation after reducing it to Bernoulli equation. We compare this solution with that given by Kaya where he used Adomian decomposition method, the solution given by chakrone where he used the Variation iteration method (VIM)and the solution given by Eq(5)in the paper of M. Javidi. We notice that our solution is better than their solutions

    The Photo Degradation of 2,3-dimethyl phenol in Drinking Water using Nano TiO2, ZnS and SnO2 Particles

    Get PDF
    The work presented in this paper is concernd with the preliminary study of semiconductors photochemical degradation of 2,3-dimethyl phenol by using powder and nanoparticles of TiO2,ZnS and SnO2. Degradation of 2,3-dimethyl phenol was carried out by using UV light at wave length of 267nm in the presence of oxygen.The absorpitivity of 2,3-dimethyl phenol decay was measured in the presence of UV light with capacity of 250 watt .The rate of degradation is increased with the weight of photocatalyst and reached  maximum value at 0.1gm (TiO2), 0.5gm (ZnO) and 1gm (SnO2).In this paper,the effects of various operating parameters of the photolytic degradation of 2,3-dimethyl phenol are presented. It was found that, different parameters, such as type of photocatalyst composition, initial substrate concentration, and amount of catalyst can play an important role on photocatalytic degradation of 2,3-dimethyl phenol. It was also found that the type and particle size of nano TiO2, SnO2 and ZnS play an important factor for accelerating the photo degradation. The activity of nano particle was found in the order: TiO2> ZnS> SnO2. The results of photodegradation are represented by Lagmuir-Hinshelwood relationship and indicate that the results are Pseudo first order. The particle size of TiO2, SnO2 and ZnS was estimated using XRD technique.  Keywords : Photodegradation, Drinking water, Nanoparticle

    QUANTITATION OF AMLODIPINE IN HUMAN PLASMA BY LCMS/MS ASSAY

    Get PDF
    ­­­­­­­­­­­­­­­­­Objective: To develop and validate a simple, precise, and rapid liquid chromatographic-tandem mass spectrometric (LC-MS/MS) method for quantification of amlodipine in human plasma.Methods: Chromatographic analysis was performed on Atlantis dC18 column (2.1 x 100 mm, 3 µm) with a mobile phase consisting of acetonitrile and 10 mM formic acid (80:20, v: v) that was delivered at a flow rate of 0.3 ml/min. The eluents were monitored using electrospray ionization in the positive ion mode set at transition 409 → 238.4 and 254.3 → 43.9 for amlodipine and tizanidine hydrochloride (IS), respectively. The method was validated for linearity, accuracy, precision, and recovery as per US-FDA guidelines.Results: The retention times of amlodipine and tizanidine (IS) were 1.26 and 1.22 respectively. The relationship between amlodipine concentration and peak height ratio of amlodipine to the IS was linear (R2³ 0.9868) in the range of 0.2–20 ng/ml, and the intra-and inter-day coefficient of variations and bias were ≤14.4% and ≤13.6% and ≤13.7% and ≤11.2%, respectively.Conclusion: The proposed method is simple, precise, and accurate for rapid measurement of amlodipine level using 0.5 ml human plasma. Further, the assay was successfully applied to determine amlodipine level in human plasma samples obtained from a healthy volunteer

    Effects of maternal age on the expression of mesenchymal stem cell markers in the components of human umbilical cord

    Get PDF
    Introduction. Although the human umbilical cord (UC) has been previously considered a medical waste, its use as a main source of fetal stem cells for regenerative medicine applications has increased over the past few years. The aim of the study was to assess the impact of the maternal age on the expression of mesenchymal stem cells (MSC) markers CD105 and CD29 in the different areas of human UC. Material and methods. In this comparative cross sectional study, one hundred term UCs from five maternal age groups (20–45 years) were collected after delivery from healthy mothers and were processed to assess both immuno- and gene expression of CD105 and CD29 surface antigen markers using immunohistochemical and RT-PCR techniques. Results. The immunoexpression of CD105 and CD29 in the amniotic membrane (AM) and Wharton’s jelly (WJ), the umbilical artery (UA) and the umbilical vein (UV) showed significant negative correlation with the maternal age (p < 0.001). Reduced amount of cells as well as the studied MSC markers and their gene expression levels were documented in older age mothers. CD105-positive MSCs were more abundant in the UA, whereas CD29-positive MSCs were more abundant in the AM and WJ. Conclusion. The decreased expression of CD105 and CD29 MSCs markers with age suggests that selective isolation of MSCs from Wharton’s jelly, umbilical artery or umbilical vein of younger mothers should be recommended

    Determination Of Aerosol Optical Thickness From Spectral Sky Transmittance.

    Get PDF
    The objective of this study is to test the feasibility of the proposed technique for retrieving spectral aerosol optical thickness (AOT) from the spectral transmittance measurements. The measurements have been acquired around Penang Island, Malaysia. Ground-based measurements were made with a handheld spectroradiometer. The measured spectral transmittance data were then converted to AOT values 6 spectral bands between 400 and 900 nm. Spectral AOT maps were generated using Kriging interpolation method for the 6 spectral bands. Air quality map was produced using this technique

    Cellular Transplantation-Based Therapeutic Strategies for Spinal Cord Injuries: Preclinical and Clinical Updates

    Get PDF
    Spinal cord injury (SCI) is a distressing neurological condition that causes loss of neural tissue, with subsequent damages to neural circuitry, and loss of sensorimotor function. The SCIs have an estimated incidence rate of ~80 cases per million populations. Till date, no ratified effective therapeutic strategy for SCIs exist; however, recent advancements in regenerative medicines to protect and regenerate damaged/lost neural tissues following SCIs have shown promising results in preclinical and clinical trials. Moreover, there is a greater need to fully understand underlying mechanisms following cellular transplantation that can be achieved through proper differentiation of desired cell type, and their in-vivo tracking of migration, proliferation and integration into the host system. Furthermore, techniques that can prevent teratomas formation following cellular transplantation have been reported. In addition to the ongoing comprehensive neuroregenerative and neuroprotective therapeutic strategies for SCIs, novel technologies are emerging including neuroscience-based computational and robotic rehabilitational therapies. These improved strategies in combination with cell-based therapeutic approaches are opening new avenues for future research to completely cure SCIs. Herein, we intended to review pathophysiological mechanisms following SCI, preclinical and clinical updates of cellular transplantation, the extent of success from these transplantations, associated controversies and other emerging technologies
    corecore